H. Lundbeck A/S (HLBBF)
6.64
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
H. Lundbeck Shareholders Equity (Quarterly) : 4.109B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.109B |
| March 31, 2026 | 3.951B |
| December 31, 2025 | 3.916B |
| September 30, 2025 | 3.959B |
| June 30, 2025 | 3.806B |
| March 31, 2025 | 3.558B |
| December 31, 2024 | 3.473B |
| September 30, 2024 | 3.569B |
| June 30, 2024 | 3.337B |
| March 31, 2024 | 3.248B |
| December 31, 2023 | 3.267B |
| September 30, 2023 | 3.167B |
| June 30, 2023 | 3.161B |
| March 31, 2023 | 3.060B |
| December 31, 2022 | 2.982B |
| September 30, 2022 | 2.756B |
| June 30, 2022 | 2.755B |
| March 31, 2022 | 2.759B |
| December 31, 2021 | 2.795B |
| September 30, 2021 | 2.818B |
| June 30, 2021 | 2.797B |
| March 31, 2021 | 2.722B |
| December 31, 2020 | 2.790B |
| September 30, 2020 | 2.635B |
| June 30, 2020 | 2.502B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.388B |
| December 31, 2019 | 2.521B |
| September 30, 2019 | 2.098B |
| June 30, 2019 | 2.060B |
| March 31, 2019 | 1.913B |
| December 31, 2018 | 2.183B |
| September 30, 2018 | 2.108B |
| June 30, 2018 | 1.968B |
| March 31, 2018 | 1.919B |
| December 31, 2017 | 1.965B |
| September 30, 2017 | 1.834B |
| June 30, 2017 | 1.641B |
| March 31, 2017 | 1.413B |
| December 31, 2016 | 1.375B |
| September 30, 2016 | 1.382B |
| June 30, 2016 | 1.323B |
| March 31, 2016 | 1.336B |
| December 31, 2015 | 1.279B |
| September 30, 2015 | 1.346B |
| June 30, 2015 | 1.521B |
| March 31, 2015 | 2.057B |
| December 31, 2014 | 2.198B |
| September 30, 2014 | 2.369B |
| June 30, 2014 | 2.462B |
| March 31, 2014 | 2.448B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 33.84B |
| ALK-Abello A/S | 1.062B |
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.061B |
| Total Liabilities (Quarterly) | 3.952B |
| Debt to Equity Ratio | 0.3505 |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 2.32% |